BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
Published in Nature Medicine
Contact Us To Get Started!
Work with us – your premier oncology partner – to optimize cancer care for patients